Precision Medicine is a rapidly evolving market, with technologies such as liquid biopsy, gene therapy, and spatial omic imaging set to change treatment paradigms and improve clinical outcomes for patients. However, this complexity offers unique challenges for our clients as they grapple with the impact Precision Medicine will have across their business - from R&D to supply chain, through to commercialization, and also as they seek to acquire new technologies through licensing or acquisition. Our industry depth, decades long experience, and local market knowledge means we deliver the critical insights needed to inform the key strategic decisions our clients must take to be market leaders in Precision Medicine.
Click on the video to watch our global and US HCLS Deal Advisory and Strategy leader Kristin Pothier at the 2023 JP Morgan Healthcare Conference as she leads a panel discussion on the challenges and opportunities in the global precision medicine field.
Industry insights and trends, one click away.